http://www.legislation.gov.uk/id/uksi/2019/775

http://www.legislation.gov.uk/uksi/2019/775/regulation/183/2020-12-31

The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019

text

text/xml

EXITING THE EUROPEAN UNION

MEDICINES

Statute Law Database

2024-05-16

Expert Participation

2020-12-31

These Regulations are made in exercise of the powers conferred by section 8(1) of the European Union (Withdrawal) Act 2018 (c. 16) in order to address failures of retained EU law to operate effectively and other deficiencies (in particular under section 8(2)(a), (b), (c), (d), (f) and (g) and (6)) arising from the withdrawal of the United Kingdom from the European Union. They are also made under paragraphs 1(1) and 7(2) of Schedule 4 to the European Union (Withdrawal) Act 2018, insofar as they make provision in relation to fees.

The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019

reg. 17(4)

The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019

Sch. 1

para. 3

reg. 1

The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019

PART 12Amendment of Part 12 (dealings with medicinal products)

Amendment of regulation 217A (requirements for prescriptions to be dispensed in an EEA State)I1183

1

Regulation 217A M1 is amended as follows.

2

In the heading, omit “other than the UK”.

3

In paragraph (2)(a), omit “other than the UK”.

Annotations:

Commencement Information

Reg. 183 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

Marginal Citations

Regulation 217A was inserted by S.I. 2014/490.